Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest update is out from XBiotech ( (XBIT) ).
XBiotech Inc. has appointed Dr. Tak W. Mak to its Board of Directors, filling an existing vacancy. Dr. Mak, a distinguished scientist known for his groundbreaking work in immunology, will serve until the next annual general meeting. His contributions to the field, including the identification of the immune checkpoint inhibitor CTLA-4, have significantly impacted oncology therapeutics. This appointment is expected to enhance XBiotech’s leadership and innovation in the industry.
More about XBiotech
YTD Price Performance: 2.25%
Average Trading Volume: 61,993
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $124.7M
Learn more about XBIT stock on TipRanks’ Stock Analysis page.
